Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Heparin sodium 5,000units/5ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Dalteparin sodium 10,000units/0.4ml solution for injection pre-filled syringes |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Dalteparin sodium 15,000units/0.6ml solution for injection pre-filled syringes |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Methylphenidate 40mg modified-release capsules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Fluconazole 150mg capsule and Clotrimazole 2% cream |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Pamidronate disodium 60mg/20ml solution for infusion vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Sodium glycerophosphate 4.32g/20ml solution for infusion vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Iron sucrose 50mg/2.5ml solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Tinzaparin sodium 14,000units/0.7ml solution for injection pre-filled syringes |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Tinzaparin sodium 4,500units/0.45ml solution for injection pre-filled syringes |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Tinzaparin sodium 2,500units/0.25ml solution for injection pre-filled syringes |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Dipyridamole 200mg modified-release / Aspirin 25mg capsules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Nonacog alfa 1,000unit powder and solvent for solution for infusion vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Factor XIII 250unit powder and solvent for solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Factor XIII 1,250unit powder and solvent for solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Methylnaltrexone bromide 12mg/0.6ml solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Fesoterodine 8mg modified-release tablets |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Mirabegron 25mg modified-release tablets |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Salmeterol 50micrograms/dose dry powder inhaler |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Theophylline 250mg modified-release tablets |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Budesonide 100micrograms/dose dry powder inhaler |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Loratadine 5mg/5ml oral solution |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Mizolastine 10mg modified-release tablets |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Chlorpromazine 25mg/5ml oral solution |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Trifluoperazine 1mg/5ml oral solution sugar free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Zuclopenthixol acetate 50mg/1ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Flupentixol 200mg/1ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Zuclopenthixol decanoate 500mg/1ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Dihydrocodeine 10mg/5ml oral solution |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Morphine 100mg modified-release capsules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Rizatriptan 10mg oral lyophilisates sugar free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Topiramate 25mg capsules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Nicotine 10mg/16hours transdermal patches |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Co-amoxiclav 400mg/57mg/5ml oral suspension sugar free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Minocycline 100mg modified-release capsules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Metronidazole 500mg/100ml infusion 100ml bags |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Ofloxacin 200mg/100ml solution for infusion bottles |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Insulin soluble human 100units/ml solution for injection 10ml vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Insulin protamine zinc bovine 100units/ml suspension for injection 10ml vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Estradiol 40micrograms/24hours transdermal patches |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Somatropin (rbe) 24mg powder and solvent for solution for injection cartridges |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Terlipressin 1mg powder and solvent for solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Oxybutynin 2.5mg/5ml oral solution |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Cytarabine 500mg/25ml solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Cytarabine 100mg/1ml solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Vinblastine 10mg/10ml solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Vincristine 2mg/2ml solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Vinorelbine 10mg/1ml solution for infusion vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Cladribine 10mg/10ml solution for infusion vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Octreotide 100micrograms/1ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Triptorelin acetate 3mg powder and solvent for suspension for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Etodolac 600mg modified-release tablets |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Prednisolone 25mg/1ml suspension for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Triamcinolone acetonide 50mg/5ml suspension for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Pilocarpine nitrate 2% eye drops 0.5ml unit dose preservative free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Oxybuprocaine 0.4% eye drops 0.5ml unit dose preservative free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Fluorescein 1% eye drops 0.5ml unit dose preservative free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Triamcinolone 55micrograms/dose nasal spray |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Benzocaine 1mg/dose oromucosal spray sugar free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Chlorhexidine gluconate 0.2% mouthwash |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Povidone-Iodine 2.5% dry powder spray |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Povidone-Iodine 10% antiseptic solution |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Midazolam 10mg/5ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Cisatracurium besilate 20mg/10ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Econazole 1% eye drops preservative free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Potassium chloride 0.2% (potassium 27mmol/1litre) / Sodium chloride 0.9% infusion 1litre bags |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Potassium chloride 0.3% (potassium 40mmol/1litre) / Sodium chloride 0.9% infusion 1litre bags |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Hyoscine hydrobromide 600micrograms/1ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Budesonide 200micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Topiramate 50mg capsules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Mesalazine 500mg modified-release tablets |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Ursodeoxycholic acid 250mg/5ml oral suspension sugar free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Indapamide 1.5mg modified-release tablets |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Furosemide 40mg/5ml oral solution sugar free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Furosemide 50mg/5ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Etanercept 25mg powder and solvent for solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Midazolam 50mg/10ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Midazolam 5mg/5ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Epoetin alfa 6,000units/0.6ml solution for injection pre-filled syringes |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Omeprazole 40mg dispersible gastro-resistant tablets |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Paclitaxel 300mg/50ml solution for infusion vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Sodium chloride 0.9% solution for injection 10ml vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Edrophonium chloride 150mg/15ml solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Diltiazem 90mg modified-release tablets |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Insulin glargine 100units/ml solution for injection 3ml cartridges |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Sodium chloride 0.9% solution for injection 20ml vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Mannitol 50g/250ml (20%) infusion bags |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Cimetidine 200mg/5ml oral solution sugar free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Beclometasone 50micrograms/dose inhaler CFC free |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Palonosetron 250micrograms/5ml solution for injection vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Felodipine 5mg modified-release tablets |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Glyceryl trinitrate 5mg/5ml solution for infusion ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Glyceryl trinitrate 10mg/24hours transdermal patches |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Pentoxifylline 400mg modified-release tablets |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Heparin sodium 10,000units/10ml solution for injection ampoules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Bevacizumab 100mg/4ml solution for infusion vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Bevacizumab 400mg/16ml solution for infusion vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Methylphenidate 10mg modified-release capsules |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Glatiramer acetate 20mg/1ml solution for injection pre-filled syringes |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|
Levetiracetam 500mg/5ml solution for infusion vials |
VMP non-availability indicator |
False |
Available |
Inferred relationship |
Existential restriction modifier |
|